HB 6020 Michigan House · 2025-2026 Regular Session

Health: research; participation in ibogaine clinical trials; provide for. Amends sec. 7212 of 1978 PA 368 (MCL 333.7212) & adds secs. 2222, 2222a & 2222b.

This bill amends Michigan's Public Health Code to create a legal framework for clinical trials involving ibogaine, a substance used to treat substance use disorders. It directly affects researchers, healthcare providers, and participants by establishing specific rules for how these studies can be conducted within the state. The legislation adds new sections to the code that define the requirements for obtaining approval, ensuring participant safety, and reporting data for these trials. By updating existing laws and adding new provisions, the bill aims to facilitate regulated medical research on ibogaine while maintaining oversight by state health authorities.
Bill status passed 3 of 5 stages cleared
Introduction
May 2026
Committee Review
Jun 2026
House Passage
Jun 2026
Senate Passage
Governor
Introduced May 21, 2026 Last action Jun 9, 2026
Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
6
Key actions
2
Committee
2
Jun 9, 2026
Lower · Passed
recommendation concurred in
lower
Jun 9, 2026
Lower · Passed
reported with recommendation for referral to Committee on Rules
lower
May 21, 2026
Committee
referred to Committee on Families and Veterans
lower
May 21, 2026
Introduced
introduced by Representative Rep. Jaime Greene
lower
1 primary · 21 co-sponsors

Sponsors